☆ 4.1 Letter

Levodopa Equivalent Dose Conversion Factors: An Updated Proposal Including Opicapone and Safinamide

MOVEMENT DISORDERS CLINICAL PRACTICE (2020)

Get Full Text
Add to Collection

Journal

MOVEMENT DISORDERS CLINICAL PRACTICE
Volume 7, Issue 3, Pages 343-345

Publisher

WILEY
DOI: 10.1002/mdc3.12921

Keywords

levodopa equivalent dose; LED; opicapone; safinamide

Categories

Clinical Neurology

Funding

  1. EU [634821]
  2. Deutsche Forschungsgemeinschaft (DFG) [MO 2088/5-1]

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.